Systematic ReviewResearchPatient Education

German prescription digital apps reduced depression symptoms, but evidence was concentrated

Scientific reports (PubMed)Sep 11, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A systematic review and meta-analysis found that prescription-eligible digital applications in Germany reduced depression and generalized-anxiety symptom severity compared with controls, but the evidence was dominated by a small number of applications.

What NurseJet pulled from the source

The review included 19 randomized trials with 4,078 participants. For depression, the pooled effect immediately after treatment was a standardized mean difference of -0.49 (95% CI -0.65 to -0.32).

Why this matters for nurses

Digital tools may extend access to structured mental-health support, but nurses should avoid generalizing an average effect to every app or patient and should recognize the limited anxiety and real-world evidence.

Bedside takeaway

Treat digital apps as adjuncts and assess the specific product, symptoms, and safety context.

Key takeaways

Follow-up evidence for depression came from one application across four comparisons and showed a smaller pooled effect.
Evidence for generalized anxiety disorder was limited to two studies.
The authors cautioned that results should not be treated as equally representative of every prescription-eligible digital application.

Practice implications

Ask which digital intervention a patient is using, reinforce that it complements the established treatment plan, and monitor symptoms and safety concerns through the usual mental-health pathway.

Limitations & cautions

Abstract-only summary. Evidence was concentrated in a few applications, anxiety data were sparse, and the authors called for more real-world research on effectiveness, quality, and implementation.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Scientific reports (PubMed)

Scientific reports (PubMed). Efficacy of prescription-eligible digital health applications for depression and generalized anxiety disorder in Germany: a systematic review and meta-analysis.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42728340/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Frontiers in Public Health (PubMed)Sep 3, 2026Research Article

A pilot cluster-randomized trial found that a staff-mediated doll-therapy care package was feasible and produced a preliminary reduction in behavioral and psychological symptoms among Chinese nursing-home residents with dementia.

Geriatrics PsychAI summaryReview source

Research ArticleResearchPatient EducationWorkflowAI summary · original source linked below

Six nursing homes enrolled 142 residents, and 130 completed 12-week follow-up. The intervention group had greater improvement on the 12-item Neuropsychiatric Inventory at 6 and 12 weeks, but psychotropic medication doses did not differ and functional improvement was not sustained.

Key takeaways

Most intervention participants attended at least six of eight sessions, and mean delivery fidelity was 94.1%.
Six possibly or probably related events were mild or moderate, with no related serious event.
Staff and family interviews emphasized non-deceptive introductions, respect for refusal, training, and recognition that some residents had no response or an adverse response.

Why this matters on shift

Residential-care nurses balance nonpharmacologic symptom support with dignity, consent, safety, and individual response. The pilot offers a carefully bounded person-centered option while showing that it did not reduce psychotropic doses and is not appropriate for every resident.

Bedside takeaway

If doll therapy is in the care plan, use a non-deceptive approach, respect refusal, and monitor each resident's response.

Nursing implications

Use doll therapy only within an approved individualized care plan, introduce it without deception, observe the resident's verbal and nonverbal response, and stop when the resident refuses or becomes distressed. Continue assessment for unmet physical, environmental, and psychosocial needs under facility protocol.

Limitations & cautions

This exploratory study involved only six nursing homes, lacked an attention-control condition, and was not designed as definitive effectiveness evidence. Medication effects were imprecise, functional improvement was not sustained, and findings may not generalize beyond the studied care setting.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Frontiers in Public Health (PubMed). Staff-mediated doll therapy in Chinese residential dementia care: an exploratory pilot and feasibility mixed-methods cluster randomized clinical trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Journal of International Medical Research (PubMed)Sep 17, 2026Systematic Review

A systematic review of randomized trials found no high-certainty evidence that adding cognitive behavioral therapy for insomnia reliably improves complete benzodiazepine-receptor-agonist or Z-drug discontinuation, although it may support insomnia coping during individualized tapering.

Psych Med-SurgAI summaryReview source

Systematic ReviewResearchMedication SafetyPatient EducationAI summary · original source linked below

Across 13 trials, early complete discontinuation favored CBT-I-assisted care but was uncertain (6 trials, 298 participants; RR 1.35, 95% CI 0.87 to 2.11). Post-treatment insomnia severity was lower with CBT-I in three small trials, while long-term discontinuation evidence was highly uncertain.

Key takeaways

The pooled early-discontinuation estimate did not establish a reliable benefit because its confidence interval included no difference and heterogeneity was substantial.
Complete discontinuation at the longest follow-up was highly uncertain, and dose-reduction results could not be pooled because definitions and time points varied.
CBT-I-assisted interventions lowered post-treatment insomnia-severity scores in three small trials, but the evidence remained uncertain.

Why this matters on shift

Nurses often identify long-term sedative-hypnotic use, falls, cognitive effects, withdrawal concerns, and rebound insomnia. The review supports presenting CBT-I as a possible aid within a supervised deprescribing plan, not as a guarantee of medication discontinuation.

Bedside takeaway

Use CBT-I as a possible support within supervised deprescribing, not as a promise of complete sedative-hypnotic discontinuation.

Nursing implications

Reconcile benzodiazepine and Z-drug use, duration, and fall or cognitive concerns; avoid abrupt discontinuation; and route tapering and CBT-I questions to the prescribing and behavioral-health team. Reinforce the individualized plan and monitor for withdrawal or worsening insomnia according to local protocol.

Limitations & cautions

The included trials were small and heterogeneous, long-term estimates were imprecise, dose-reduction definitions varied, and safety reporting was incomplete. The review does not establish a single CBT-I or tapering protocol.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of International Medical Research (PubMed). Cognitive behavioral therapy for insomnia-assisted discontinuation or reduction of benzodiazepine receptor agonists and Z-drugs in chronic insomnia: A systematic review and meta-analysis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Supportive Care in Cancer (PubMed)Sep 17, 2026Research Article

In a three-group randomized trial of breast cancer survivors, seven weeks of true self-acupressure improved the combined fatigue, sleep-disturbance, and depression symptom score compared with sham self-acupressure and usual care through 19 weeks.

Oncology PsychAI summaryReview source

Research ArticleResearchPatient EducationAI summary · original source linked below

The trial assigned 108 participants equally to true self-acupressure, sham self-acupressure, or usual care, and 93 completed it. The true-acupressure group had better cluster scores than both comparison groups at weeks 7 and 19; no adverse events were reported.

Key takeaways

Sleep-quality and depression scores were better with true self-acupressure than with both comparison groups at the end of treatment and follow-up.
Fatigue was lower than usual care at both time points, but the difference from sham acupressure was statistically significant only at follow-up.
Quality of life was better than usual care at both time points, while the difference from sham acupressure was not statistically significant immediately after treatment.

Why this matters on shift

Fatigue, sleep disturbance, and depressive symptoms frequently overlap during breast cancer survivorship. The trial identifies a low-resource supportive option worth further study, while the small sample and mixed sham comparisons argue against overstating the effect.

Bedside takeaway

Treat self-acupressure as an adjunctive survivorship option and continue structured assessment of fatigue, sleep, and mood.

Nursing implications

Assess fatigue, sleep, mood, and quality-of-life concerns together and escalate significant or worsening symptoms through the survivorship pathway. If self-acupressure is available within an approved supportive-care plan, present it as an adjunct rather than a replacement for evaluation or treatment.

Limitations & cautions

This was a small trial with 108 randomized participants and 93 completers. Some outcomes did not differ from sham treatment immediately after the intervention, clinical effect sizes were not reported in the abstract, and cost-effectiveness remains unknown.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Supportive Care in Cancer (PubMed). Effects of self-acupressure on the fatigue-sleep disturbance-depression symptom cluster in breast cancer survivors: a phase III randomised controlled trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Staff-mediated doll therapy showed a preliminary behavioral benefit in dementia care

CBT for insomnia did not reliably improve complete benzodiazepine or Z-drug discontinuation

Self-acupressure improved a fatigue, sleep, and depression symptom cluster in one small trial